Producer
Boai NKY Pharmaceuticals Ltd.
Major Chinese producer of PVP/povidone, crospovidone and copovidone pharmaceutical excipients; one of the largest PVP makers globally.
1
Inputs supplied
1
Goods downstream
1
Facilities
0
Stories
What they make
1 input Boai NKY Pharmaceuticals Ltd. supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Boai NKY Pharmaceuticals Ltd. makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
PVP (Povidone) & Pharmaceutical Grade Excipients
55%PVP for Personal Care & Industrial Applications
25%N-Vinylpyrrolidone (NVP) Monomer & Intermediates
20%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Did you know2024
Povidone (PVP), which Boai NKY manufactures as a pharmaceutical tablet binder, is the polymer backbone of povidone-iodine — the amber-brown antiseptic used as surgical scrub (Betadine), wound antiseptic, and pre-operative skin preparation in hospitals worldwide. When complexed with iodine, PVP releases iodine slowly as an antimicrobial agent while the polymer reduces iodine's toxicity and staining. The PVP that holds a heart medication tablet together and the PVP in the surgical scrub that prevents post-operative infection are chemically identical molecules from the same production process. During the COVID-19 pandemic, povidone-iodine demand surged in Asia as a nasal/oral antiseptic prophylactic — directly competing with pharmaceutical tablet manufacturing for the same PVP supply from Chinese producers including Boai NKY. A single Henan factory's production schedule simultaneously determines the supply of pharmaceutical tablet binders and global hospital wound care antiseptics.
Boai NKY Pharmaceuticals Ltd. ↗Concentration2023
China produces approximately 50-60% of global PVP supply through Boai NKY and other Henan/Shandong producers. BASF (Germany) is the primary non-Chinese producer with the Kollidon brand, maintaining Western supply chain resilience. The global pharmaceutical industry's extensive use of PVP as a binder in tablet manufacturing means that a Chinese PVP supply disruption (export restriction, production accident, regulatory closure) would affect pharmaceutical manufacturing globally for any drug in tablet form that uses PVP as a binder — which includes a large fraction of generic oral medications. In 2020-2021, PVP shortages were reported as COVID-19 disrupted supply chains, with povidone-iodine demand competing with pharmaceutical manufacturing for available supply. The dependence of global pharmaceutical tablet manufacturing on Chinese PVP suppliers mirrors the broader API (active pharmaceutical ingredient) supply concentration risk that US drug regulators have flagged as a systemic risk.
U.S. Food and Drug Administration ↗Origin2024
Boai NKY Pharmaceuticals is based in Jiaozuo, Henan Province — a major industrial chemistry region in central China. Henan was historically known for coal mining and metallurgy; its chemical industry grew partly from coal-to-chemicals infrastructure. Boai NKY developed pyrrolidone chemistry expertise to manufacture N-vinylpyrrolidone (NVP) monomer and PVP polymers, climbing from local API excipient supplier to one of the world's largest PVP producers. The company's growth reflects China's broader transition from bulk commodity chemical production toward specialty pharmaceutical excipients — a shift that captured global market share by undercutting Western producers on cost while meeting USP/EP pharmacopoeia quality standards.
Boai NKY Pharmaceuticals Ltd. ↗